IFN-γ induces apoptosis in HL-60 cells through decreased Bcl-2 and increased Bak expression

Journal of Interferon and Cytokine Research

Volumn 28, Issue 2, 2008, Pages 65-72

  Zhou, Yan ^a   Weyman, Crystal M ^a   Liu, Hongli ^a   Almassan, Alexandru ^b   Zhou, Aimin ^a,b  

^a CLEVELAND STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CASPASE 3; CYTOCHROME C; GAMMA INTERFERON; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; PROTEIN BAK; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA FRAGMENTATION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; LEUKEMIA CELL; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CASPASE 3; CELL PROLIFERATION; CYTOCHROMES C; HL-60 CELLS; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-BETA; K562 CELLS; LEUKEMIA; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 39449115988     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0025     Document Type: Article

References (32)

1. Akbar AN, Lord JM, Salmon M. 2000. IFN-alpha and IFN-beta: a link between immune memory and chronic inflammation. Immunol Today 21(7):337-342.
2. Barton C, Davies D, Balkwill F, Burke F. 2005. Involvement of both intrinsic and extrinsic pathways in IFN-gamma-induced apoptosis that are enhanced with cisplatin. Eur J Cancer 41(10):1474-1486.
3. Biron CA. 1998. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin Immunol 10(5):383-390.
4. Borden EC, Lindner D, Dreicer R, Hussein M, Peereboom D. 2000. Second-generation interferons for cancer: clinical targets. Semin Cancer Biol 10(2):125-144.
5. Borden EC, Parkinson D. 1998. A perspective on the clinical effectiveness and tolerance of interferon-alpha. Semin Oncol 25(1 Suppl 1):3-8.
6. Chao DT, Korsmeyer SJ. 1998. BCL-2 family: regulators of cell death. Annu Rev Immunol 16:395-419.
7. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8(3):237-249.
8. De Rose V, Cappello P, Sorbello V, Ceccarini B, Gani F, Bosticardo M, Fassio S, Novelli F. 2004. IFN-gamma inhibits the proliferation of allergen-activated T lymphocytes from atopic, asthmatic patients by inducing Fas/FasL-mediated apoptosis. J Leukoc Biol 76(2):423-432.
9. Giatromanolaki A, Koukourakis MI, Ritis K, Mimidis K, Sivridis E. 2004. Interferon regulatory factor-1 (IRF-1) suppression and derepression during endometrial tumorigenesis and cancer progression. Cytokine 26(4):164-168.
10. Gollob JA, Sciambi CJ, Huang Z, Dressman HK. 2005. Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma. Cancer Res 65(19):8869-8877.
11. Han J, Goldstein LA, Gastman BR, Rabinowich H. 2006. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J Biol Chem 281(15):10153-10163.
12. Harada H, Taniguchi T, Tanaka N. 1998. The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie 80(8-9):641-650.
13. Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK. 2003. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Cancer Res 63(7):1712-1721.
14. Kim EJ, Lee JM, Namkoong SE, Um SJ, Park JS. 2002. Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma cells. J Cell Biochem 85(2):369-380.
15. Kim PK, Armstrong M, Liu Y, Yan P, Bucher B, Zuckerbraun BS, Gambotto A, Billiar TR, Yim JH. 2004. IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo. Oncogene 23(5):1125-1135.
16. Kirchhoff S, Koromilas AE, Schaper F, Grashoff M, Sonenberg N, Hauser H. 1995. IRF-1 induced cell growth inhibition and interferon induction require the activity of the protein kinase PKR. Oncogene 11(3):439-445.
17. McKenzie MD, Dudek NL, Mariana L, Chong MM, Trapani JA, Kay TW, Thomas HE. 2006. Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL. Int Immunol 18(6):837-846.
18. Newmeyer DD, Ferguson-Miller S. 2003. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112(4):481-490.
19. Panaretakis T, Pokrovskaja K, Shoshan MC, GrandÈr D. 2003. Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Oncogene 22(29):4543-4556.
20. Park SY, Seol JW, Lee YJ, Cho JH, Kang HS, Kim IS, Park SH, Kim TH, Yim JH, Kim M, Billiar TR, Seol DW. 2004. IFN-gamma enhances TRAIL-induced apoptosis through IRF-1. Eur J Biochem 271:4222-4228.
21. Pedersen KB, Andersen K, Fodstad O, Maelandsmo GM. 2004. Sensitization of interferon-gamma induced apoptosis in human osteosarcoma cells by extracellular S100A4. BMC Cancer Aug 19;4:52.
22. Platanias LC, Fish EN. 1999. Signaling pathways activated by interferons. Exp Hematol. 27(11):1583-1592.
23. Ruiz-Ruiz C, Lopez-Rivas A. 2002. Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosisinducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells. Biochem J 365:825-832.
24. Salvesen GS, Dixit VM. 1997. Caspases: intracellular signaling by proteolysis. Cell 91(4):443-446.
25. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163-189.
26. Scorrano L, Korsmeyer SJ. 2003. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304(3):437-444.
27. Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH. 2001. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int J Cancer 93:262-268.
28. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264.
29. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T. 1996. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382:816-818.
30. Thornberry NA, Lazebnik Y. 1998. Caspases: enemies within. Science 281(5381):1312-1316.
31. Wadler S, Schwartz EL. 1997. New advances in interferon therapy of cancer. Oncologist 2(4):254-267.
32. Walter MR, Bordens R, Nagabhushan TL, Williams BR, Herberman RB, Dinarello CA, Borden EC, Trotta PP, Pestka S, Pfeffer LM. 1998. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon. Cancer Biother Radiopharm 13(3):143-154.